SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Nanjing Leads Biolabs Enrolls First Patient in LBL-024 Cancer Trial

Nanjing Leads Biolabs enrolled the first patient in a Phase Ib/II trial of LBL-024 for metastatic colorectal cancer.

Related stories